Does RANOLAZINE Cause Pulmonary hypertension? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Pulmonary hypertension have been filed in association with RANOLAZINE (Ranolazine). This represents 0.1% of all adverse event reports for RANOLAZINE.
9
Reports of Pulmonary hypertension with RANOLAZINE
0.1%
of all RANOLAZINE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Pulmonary hypertension From RANOLAZINE?
Of the 9 reports, 7 (77.8%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which RANOLAZINE Alternatives Have Lower Pulmonary hypertension Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ